Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women
NCT03807024 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1071
Last updated 2019-01-16
Summary
The knowledge of the age-specific prevalence of overactive bladder syndrome (OAB)-wet and -dry women is important for understanding the impact of aging on OAB. Thus, our aim is to describe clinically differences between OAB-wet and -dry women.
Conditions
- Urinary Bladder, Overactive
Interventions
- DIAGNOSTIC_TEST
-
Bladder diary
3-day bladder diary: The classification of OAB-wet or OAB-dry is based on the record of the three-day bladder diary of each patient. The diagnosis of OAB in each patient was based on the presence of at least one episode of urgency in her three-day bladder diary and with the absence of stress urinary incontinence. The presence of at least one episode of urgency associated incontinence was defined to be OAB-wet, otherwise, OAB-dry
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Ho-Hsiung Lin, PhD · National Taiwan University Hospital
Eligibility
- Min Age
- 20 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-01
- Primary Completion
- 2018-01-01
- Completion
- 2018-01-01
More Related Trials
-
Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing
NCT01819168 ·Status: COMPLETED
-
Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing
NCT03251300 ·Status: UNKNOWN ·Phase: PHASE4
-
Developing a Simple Test to Diagnose Overactive Bladder
NCT05572918 ·Status: UNKNOWN
-
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 ·Status: COMPLETED
-
Diversity in Patients With OAB
NCT05903105 ·Status: NOT_YET_RECRUITING
-
Risk Factors for Treatment Failure in Women With Detrusor Overactivity Receiving Combined Pharmacotherapy
NCT07337252 ·Status: COMPLETED
-
Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity
NCT03486639 ·Status: UNKNOWN
-
Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection
NCT05719285 ·Status: COMPLETED ·Phase: PHASE4
-
Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug
NCT01627145 ·Status: UNKNOWN ·Phase: NA
-
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women
NCT01684800 ·Status: COMPLETED ·Phase: PHASE2
-
Herbal Patch for Overactive Bladder
NCT03532789 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients
NCT01223937 ·Status: COMPLETED ·Phase: PHASE3
-
Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
NCT01729819 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects
NCT02905682 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder
NCT06250543 ·Status: COMPLETED ·Phase: PHASE4
-
Overactive Bladder (OAB) Drink Advice Study
NCT00982241 ·Status: WITHDRAWN ·Phase: NA
-
Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes
NCT07025642 ·Status: RECRUITING ·Phase: NA
-
The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder
NCT00553657 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence
NCT00304499 ·Status: COMPLETED ·Phase: PHASE3
-
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
NCT03817931 ·Status: COMPLETED ·Phase: PHASE4
-
Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients
NCT01876186 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder
NCT00836381 ·Status: COMPLETED ·Phase: PHASE4
-
Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions
NCT02197533 ·Status: COMPLETED ·Phase: NA
-
Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study
NCT06563193 ·Status: ENROLLING_BY_INVITATION
-
A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden
NCT03903094 ·Status: COMPLETED